PX-811013

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePX-811013
Drug Alias Nameadiponectin (Protemix)PX-811013
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin sensitizersTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammationDiabetes Mellitus, Type 2Hepatitis, Alcoholic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtemix Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtemix Corp Ltd
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes Mellitus, Type 2Hepatitis, Alcoholic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A